medigraphic.com
ISSN 2594-1518 (Electronic)
ISSN 1405-0099 (Print)

2010, Number s1

<< Back Next >>

Cir Gen 2010; 32 (s1)

Hepatocarcinoma

Mercado MÁ

Language: Spanish
References: 18
Page: 5-8
PDF size: 35.97 Kb.


Text Extraction




REFERENCES

  1. Colombo M. Surveillance and prevention of hepatocellular carcinoma. En Falk Symposium 160. Pathogenesis and clinical practice in gastroenterology. 2008 Springer annual Falk Foundation. 239-251

  2. Sangiovanni A, Del Ninno E, Fasani P, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected Turing surveillance. Gastroenterology 2004; 126: 1005-1014.

  3. Kojiro M, Roskams T. Early hepatocellular carcinoma and dysplastic Nodules. Semin Diver Dir 2005; 25: 133-42.

  4. Forner A, Villana R, Ayusco C, Bianchi L, et al. Diagnosis of hepatic nodules 20 Mn or smaller in cirrhosis: prospective validation of the Non invasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008; 47: 97-104.

  5. Sala M, Forner A, Varela M, Bruix J. Prognostic prediction in patients with hepatocellular carcinoma. Jemin Liver Dis 2005; 25: 171-80.

  6. Geissler M, Kramer S. Hepatozelluläres karzinom: diagnosticscher algorithmus. Viszeral Medizin 2009; 25: 79-83.

  7. Levy I, Greig PD, Gallinger S, Langer B, Sherman M. Resection of hepatocellular carcinoma without preoperative tumor biopsy. Ann Surg 2004; 234: 208-209.

  8. Simons JP, Ng S, C Hill Js, Shah SA, Zhou Z. A simple risk score predicts inpatient mortality after liver resection for hepatocellular carcinoma. HPB. 2009; 11: 3.

  9. Nathan H, Mentha G, Marques HP, Capussoh L, Majno P. Comparative performance of staging systems for early hepatocellular carcinoma. HPB 2009; 11: 16.

  10. Aloia TA, Fahy BN Fischer CP, Jones SL, Ductini A, Galati A. Predicting poor outcome following hepatectomy: analysis of 2,313 hepatectomies in the NSQIP database HPB. 2009; 11: 26.

  11. Teh SH, Hammill C, Wong L, et al. Validation for the Meld based objective scoring system. HPB 2009; 11: 26

  12. Roayaie D, Bassi D, Hiotis S, Lebow D, Schwartz M. Second hepatic resection for recurrent hepatocellular carcinoma. HPB 2009; 11: 1.

  13. Shumaccher A, Powell J, Buczkowski A, Sundamore C, Multimodal therapy for treatment of hepatocellular carcinoma : A ten year survival analysis. HPB 2009; 11: 25.

  14. Facciuto M, Pandey M, Rochon C, Rodríguez VM, Wolf DC. Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention to treat analysis in patients within and outside Milan criteria. HPB 2009; 11: 34.

  15. Belghiti J, Herrero A, Pulitano C, Fargen O, Sauvante A. Partial liver resection for HCC in patients with good liver function can challenge liver transplantation. HPB 2009; 11: 37.

  16. Nathan H, Schulick R D, Choti MA, Pawlite TM. National trends in patient treatment and procedure related mortality for hepatocellular carcinoma. HPB 2009; 11: 40.

  17. Ehrenwald E, Sieloff T, Mackenzie S, Kasari K. Transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC) using doxorubicin eluting microspheres (DEB). Initial results. HPB 2009; 11: 49.

  18. Mazaferro V, Regalic E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinoma a life expectancy and cost–effectiveness perspective. Hepatology 2001; 33: 1073-9.




2020     |     www.medigraphic.com